awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26991637-861D70EF-BDFA-42E9-A402-ED79D2AF8416
Q26991637-861D70EF-BDFA-42E9-A402-ED79D2AF8416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991637-861D70EF-BDFA-42E9-A402-ED79D2AF8416
Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance
P2860
Q26991637-861D70EF-BDFA-42E9-A402-ED79D2AF8416
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26991637-861D70EF-BDFA-42E9-A402-ED79D2AF8416
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abc977da5cbc00ff71ccf4bc73df1251bf691d25
P2860
Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors